| Literature DB >> 27542381 |
Gesa Gieseler1, Iliyana Pepelanova2, Lena Stuckenberg1, Louis Villain3, Volker Nölle4, Uwe Odenthal4, Sascha Beutel1, Ursula Rinas1, Thomas Scheper1.
Abstract
In this study, we present the development of a process for the purification of recombinant human bone morphogenetic protein-2 (rhBMP-2) using mixed-mode membrane chromatography. RhBMP-2 was produced as inclusion bodies in Escherichia coli. In vitro refolding using rapid dilution was carried out according to a previously established protocol. Different membrane chromatography phases were analyzed for their ability to purify BMP-2. A membrane phase with salt-tolerant properties resulting from mixed-mode ligand chemistry was able to selectively purify BMP-2 dimer from refolding mixtures. No further purification or polishing steps were necessary and high product purity was obtained. The produced BMP-2 exhibited a biological activity of 7.4 × 105 U/mg, comparable to commercial preparations. Mixed-mode membrane chromatography can be a valuable tool for the direct purification of proteins from solutions with high-conductivity, for example refolding buffers. In addition, in this particular case, it allowed us to circumvent the use of heparin-affinity chromatography, thus allowing the design of an animal-component-free process.Entities:
Keywords: Animal-component-free; BMP-2; Membrane adsorbers; Mixed-mode chromatography
Mesh:
Substances:
Year: 2016 PMID: 27542381 DOI: 10.1007/s00253-016-7784-1
Source DB: PubMed Journal: Appl Microbiol Biotechnol ISSN: 0175-7598 Impact factor: 4.813